Source: Annual Congress 2010 - Biomarkers for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
W. Grüning, T. Mairinger, J. Kollmeier, T. Blum, S. Griff, A. Roth, S. Stephan-Falkenau, T. Bauer (Berlin, Germany). EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre. Eur Respir J 2010; 36: Suppl. 54, 3236

Member's Comments

No comment yet.

Related content which might interest you: KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centre Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Treatment of  non-small cell lung cancer (NSCLC) - the state of the art and beyond Source: International Congress 2017 – State of the art session: "Lung cancer" Year: 2017 Survival outcomes in advance non-small cell lung cancer – A developing country scenario Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility? Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Lung cancer Source: Respipedia Article Year: 2018 Octogenarians with non-small cell lung carcinoma – Advanced disease Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 A non-small cell lung cancer modelling by endogenous κ-ras manipulation Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 Surgery for elderly early-stage non-small cell lung cancer: less or more? Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 CTLA-4, CD28, and ICOS gene polymorphisms in non-small cell lung cancer in a Polish population- case control study Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015